A High Omega-3 Fatty Acid Diet Mitigates Murine Pancreatic Precancer Development

Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
Journal of Surgical Research (Impact Factor: 1.94). 06/2009; 165(1):75-81. DOI: 10.1016/j.jss.2009.04.022
Source: PubMed

ABSTRACT Diets containing omega-3 (ω-3) fat have been associated with decreased tumor development in the colon, breast, and prostate. We assessed the effects of a diet rich in ω-3 fat on the development of pancreatic precancer in elastase (EL)-Kras transgenic mice and examined the effect of an ω-3 fatty acid on pancreatic cancer cells in vitro.
Two cohorts of EL-Kras mice were fed a high ω-3 fat diet (23% menhaden oil) for 8 and 11 mo and compared with age-matched EL-Kras mice fed standard chow (5% fat). Pancreata from all mice were scored for incidence and frequency of precancerous lesions. Immunohistochemistry was performed for proliferating cell nuclear antigen (PCNA) to assess proliferative index in lesions of mice fed either a high ω-3 or standard diet. In vitro, the effect of the ω-3 fatty acid, docosahexaenoic acid (DHA), on two pancreatic cancer cell lines was assessed. Cancer cell proliferation was assessed with an MTT assay; cell cycle analysis was performed by flow cytometry; and apoptosis was assessed with annexin/PI staining.
The incidence, frequency, and proliferative index of pancreatic precancer in EL-Kras mice was reduced in mice fed a high ω-3 fat diet compared with mice fed a standard chow. In vitro, DHA treatment resulted in a concentration-dependent decrease in proliferation through both G1/G0 cell cycle arrest and induction of apoptosis.
A high ω-3 fat diet mitigates pancreatic precancer by inhibition of cellular proliferation through induction of cell cycle arrest and apoptosis.

32 Reads
  • Source
    • "Herbal medicine has been widely used to cure or prevent diseases since ages. Many of the herbs contain phytochemicals, antioxidants, flavonoids, and dietary fibers which have shown anticancer properties [4] [5]. Teucrium polium L. (Lamiaceae), known popularly as Golden/Felty germander, is a subshrub and is native to southwest Asia and the Mediterranean region [6] [7]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The term cancer has been concomitant with despair, agony, and dreadful death. Like many other diseases, herbal therapy has been used to prevent or suppress cancer. The present study investigated the capability of the decoction of Teucrium polium L. from Lamiaceae family to protect liver cells against hepatocellular carcinoma in carcinogenesis-induced animal model. After 28 weeks of treatment with decoction of Teucrium polium L., serum biochemical markers including ALT, AST, AFP, GGT, ALP, HCY, TNF-α, α2MG, and CBG have been regulated auspiciously. Total antioxidant status also has been increased intensely. Liver lesion score in treated group was lessened and glucocorticoid activity has been intensified significantly. In conclusion, Teucrium polium L. decoction might inhibit or suppress liver cancer development.
    Evidence-based Complementary and Alternative Medicine 08/2014; 2014:1-9. DOI:10.1155/2014/726724 · 1.88 Impact Factor
  • Source
    • "Fish oil rich in n-3 polyunsaturated fatty acids has been demonstrated to reduce pancreatic tumor incidences and hepatic metastasis in the BOP-treated hamster model [71]. Enhancing effects of high fat diet and suppressive influence of n-3 polyunsaturated fatty acid-rich fish oil on development of precancerous lesions, PanINs, in K-ras mutated GEM models have also been reported [72,73]. Obesity-mediated enhancement of PanIN lesion development is associated with increased inflammation, and abrogation of TNFR1 signaling blocks tumor promotion [72]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pancreatic cancer is difficult to cure, so its prevention is very important. For this purpose, animal model studies are necessary to develop effective methods. Injection of N-nitrosobis(2-oxopropyl)amine (BOP) into Syrian golden hamsters is known to induce pancreatic ductal adenocarcinomas, the histology of which is similar to human tumors. Moreover, K-ras activation by point mutations and p16 inactivation by aberrant methylation of 5' CpG islands or by homozygous deletions have been frequently observed in common in both the hamster and humans. Thus, this chemical carcinogenesis model has an advantage of histopathological and genetic similarity to human pancreatic cancer, and it is useful to study promotive and suppressive factors. Syrian golden hamsters are in a hyperlipidemic state even under normal dietary conditions, and a ligand of peroxizome proliferator-activated receptor gamma was found to improve the hyperlipidemia and suppress pancreatic carcinogenesis. Chronic inflammation is a known important risk factor, and selective inhibitors of inducible nitric oxide synthase and cyclooxygenase-2 also have protective effects against pancreatic cancer development. Anti-inflammatory and anti-hyperlipidemic agents can thus be considered candidate chemopreventive agents deserving more attention.
    Cancers 12/2011; 3(1):582-602. DOI:10.3390/cancers3010582
  • Source
    • "Hamsters treated with BOP to induce PC þ n-6 FA-rich diet followed by n-3 or n-3, -6 and -9 FA-rich diet Decreased incidence of liver metastases in n-3 FA group. Decreased incidence of macroscopically visible pancreatic tumours in n-3 FA, although microscopic appearances are not different from other FA groups Strouch et al. (2009) (18) EL-Kras mice þ n-3 FA-rich diet or standard diet PC cell lines þ DHA Incidence, frequency and proliferation index of pancreatic pre-cancer reduced with n-3 FA-rich diet. Decrease in cell line proliferation and induction of apoptosis with DHA Funahashi et al. (2008) (19) PC cell lines þ n-3 FA or n-6 FA. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The palliative treatment of patients with advanced pancreatic cancer (APC) has undergone little advancement in the last 15 years. Novel therapies that have been investigated to extend survival have shown little benefit over existing chemotherapy regimens. Patients with APC often experience significant weight loss, which is one of the primary factors involved in declining quality of life. Recently, the ability of n-3 fatty acid rich oral preparations to attenuate or reverse tumour-related weight loss has been investigated in this patient group with encouraging results. Laboratory investigation has also yielded promising results suggesting a potential direct tumouricidal effect of n-3 fatty acids as well as the putative potentiation of existing chemotherapy regimes. The present review aims to examine the potential applications of fish oils rich in n-3 fatty acids in patients with APC, present a selection of the studies carried out to date and outline avenues of possible further clinical investigation.
    The British journal of nutrition 07/2011; 106(6):795-800. DOI:10.1017/S0007114511003060 · 3.45 Impact Factor
Show more